摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-bromoethyl)phenylacetamide | 194935-56-3

中文名称
——
中文别名
——
英文名称
N-(2-bromoethyl)phenylacetamide
英文别名
phenyl-acetic acid-(2-bromo-ethylamide);Phenylessigsaeure-(β-brom-aethylamid);Phenyl-essigsaeure-(2-brom-aethylamid);N-(2-bromoethyl)-2-phenylacetamide
N-(2-bromoethyl)phenylacetamide化学式
CAS
194935-56-3
化学式
C10H12BrNO
mdl
——
分子量
242.115
InChiKey
HENWRPFGLKDZMA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    84-85 °C
  • 沸点:
    400.7±38.0 °C(Predicted)
  • 密度:
    1.388±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthese 2-substituierter Imidazoline: 2-Benzyl-imidazolin
    摘要:
    DOI:
    10.1007/bf00897772
  • 作为产物:
    参考文献:
    名称:
    N-亚硝基偶氮唑啉的核苷和DNA加合物。
    摘要:
    代表性的咪唑啉受体药物托拉唑啉的亚硝化产物N-亚硝基偶氮唑啉与DNA,脱氧鸟苷(dG)或脱氧腺苷(dA)的反应生成包含2-苯基乙酰氨基乙基的加合物。2-苯基乙酰氨基乙基鸟嘌呤衍生物(O6-dG,O6-Gua,N2-Gua和7-Gua)和2-苯基乙酰氨基乙基腺嘌呤衍生物(1-Ade,3-Ade,7-Ade和N6-说明)。除了使用已建立的紫外光谱法确认烷基腺嘌呤的结构外,还提出了一种新的13C NMR方法来确定N-烷基化位点。结合合成的标准品,使用HPLC MS / MS方法确定所生成加合物的性质和数量。N-亚硝基偶氮唑啉与dG反应生成7-(2-苯基乙酰氨基乙基)脱氧鸟苷(主要),O6-(2-苯基乙酰氨基乙基)脱氧鸟苷和5'-O-苯基乙酰基脱氧鸟苷。N-亚硝基偶氮唑啉与dA的反应产生了1-,3-,7-,N6和5-O'-2-苯基乙酰胺基乙基腺嘌呤和dA衍生物以及几种苯基乙酰基加合物。N-亚硝基偶
    DOI:
    10.1021/tx700323k
点击查看最新优质反应信息

文献信息

  • Sulfonamide derivatives as ppar modulators
    申请人:Conner Eugene Scott
    公开号:US20060217433A1
    公开(公告)日:2006-09-28
    The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    本发明涉及一种式(I)化合物:及其药学上可接受的盐、溶液剂、水合物或立体异构体,可用于治疗或预防由过氧化物酶体增殖物激活受体(PPAR)介导的疾病,如 X 综合征、II 型糖尿病、高血糖、高脂血症、肥胖、凝血功能障碍、高血压、动脉硬化以及其他与 X 综合征和心血管疾病相关的疾病。
  • Electrogenerated Superoxide-Activated Carbon Dioxide. A New Mild and Safe Approach to Organic Carbamates
    作者:Maria Antonietta Casadei、Franco Micheletti Moracci、Giovanni Zappia、Achille Inesi、Leucio Rossi
    DOI:10.1021/jo970308h
    日期:1997.10.1
    The electrochemical reduction of O-2 (E = -1.0 V vs SCE) in dipolar aprotic solvents in the presence of CO2 gave a carboxylating reagent (O-2(.-)/CO2) able to convert amines and different types of their derivatives into carbamates. Primary and secondary aliphatic and aromatic amines were converted into the corresponding ethyl carbamates by the addition of EtI to the carbamate anions generated in the first step of the reactions. The yields were dependent on the nucleophilicity of the nitrogen atom. beta-Bromoethyl- and propylamine gave 2-oxazolidinone and tetrahydro-1,3-oxazin-2-one in moderate yields. N-Acyl or N-(alkoxycarbonyl)alkylamines bearing a leaving group at the beta position of the alkyl substituent were converted into 3-substituted-2-oxazolidinones in high yields. By using chiral substrates, enantiopure 3-alkoxycarbonyl(or acyl)-4-substituted oxazolidin-2-ones (70-85% isolated yields) were obtained. This represents a new mild and safe route to these important auxiliaries for asymmetric synthesis. Some limitations of the process are also evidenced and accounted for.
  • Synthesis and Synthetic Applications of 1-Aryl-2-alkyl-4,5-dihydro-1<i>H</i>-imidazoles
    作者:Ana M. Reverdito、Isabel A. Perillo、Alejandra Salerno
    DOI:10.1080/00397911.2011.552155
    日期:2012.7.15
    An easy synthesis of 1-aryl-2-alkyl-4,5-dihydro-1H-imidazoles 1 by cyclo-condensation of N-acyl-N'-arylethylenediamines 2 is described. Such precursors were synthesized by aminolysis of the corresponding N-(2-bromoethyl)amides 3. Cyclizations were performed using trimethylsilyl polyphosphate as a mild dehydrating agent, under microwave irradiation. Chemical properties of 1-aryl-2-alkyl-4,5-dihydro-1H-imidazoles, typical of the amidine system, were studied. Reduction of dihydroimidazoles with sodium cyanoborohydride leads regiospecifically to N-alkyl-N'-arylethylenediamines 4, and nucleophilic attack to methyl iodide leads to the corresponding 1-aryl-2-alkyl-3-methyl-4,5-dihydro-1H-imidazolium salts 5.
  • Elfeldt, Chemische Berichte, 1891, vol. 24, p. 3220
    作者:Elfeldt
    DOI:——
    日期:——
  • SULFONAMIDE DERIVATIVES AS PPAR MODULATORS
    申请人:ELI LILLY AND COMPANY
    公开号:EP1597248A2
    公开(公告)日:2005-11-23
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐